Work

Abstract C008: NFIL3 emerges as a driver of CAR T cell dysfunction from integrated in vivo/in vitro CRISPR screen

Year: 2026

Type: conference-abstract

Source: Cancer Immunology Research

DOI: 10.1158/2326-6074.io2026-c008

Authors: Nayan Jain, Yuzhe Shi, Celina May, Sneha Mitra, Philip Bucher, Anton Dobrin, Zeguo Zhao, Sophie Hanina, Vinagolu Rajasekhar, Christina Leslie, Francisco Sánchez-Rivera, Judith Feucht, Michel Sadelain

Institutions: Columbia University, University of Tübingen, Memorial Sloan Kettering Cancer Center, University of Toronto, Massachusetts Institute of Technology

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130308635

Cites:

Cited by:

Related to: